Multimedia
View More
Hear from global experts in this on-demand Webcast capturing a live CCO Webinar focused on leveraging PARP inhibitors and chemotherapy for optimal treatment of pancreatic cancer with BRCA1/2 and other DNA damage repair gene alterations.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.